|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.44 USD | +2.43% |
|
-2.29% | -11.55% |
| 05-01 | UBS Adjusts Price Target on Exponent to $75 From $85, Maintains Neutral Rating | MT |
| 04-30 | Exponent, Inc., Q1 2026 Earnings Call, Apr 30, 2026 |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 3 | ||||||||
| 16 | ||||||||
| 11 | ||||||||
| 15 | ||||||||
| 17 | ||||||||
| 13 | ||||||||
| 13 | ||||||||
| 12 | ||||||||
| 3 | ||||||||
| 11 | ||||||||
| 8 | ||||||||
| 2 | ||||||||
| 8 | ||||||||
| 8 | ||||||||
| 14 | ||||||||
| 3 | ||||||||
| 5 | ||||||||
| 12 | ||||||||
| 2 | ||||||||
| Average | 9 | |||||||
| Weighted average by Cap. | 13 |
- Stock Market
- Stocks
- EXPO Stock
- Sector Exponent, Inc.
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
















